In Vitro Diagnostics: Rapid Antigen Tests

We are one of the leading compaies in Japan in the field of Rapid Antigen Tests, especially, Capilia TB-NEO, Capilia Flu NEO, Capilia Adeno NEO, Capilia RSV NEO.

We are specializing in developing, manufacturing and selling rapid diagnostic test kits for infectious diseases and and research reagents for more than 30 years.

Our strength is to commercialize products that include customer’s request by having departments from research and development, manufacturing and sales.

We have been widely known for high-quality products and customer services by hospitals, clinics, research institutes and biotech start-ups.

With the advantages of shortening the test time and making an examinee feel familiar with the test, it helps to contribute to more timely and appropriate medical treatment and nursing care, prevent disease, and improve overall health. Furthermore, it is the test that helps to improve the quality of medical care, quality of life and satisfaction of an examinee.

It is preferable that the Israeli company will do the import procedures as well as the distribution.

Virus test kits:

・SARS-CoV-2 antigen rapid test（coronavirus）

・Flu antigen rapid test (influenza）

・Adeno virus antigen rapid test（adenovirus）

・RS virus antigen rapid test（RS virus）

・TB antigen rapid test（tubercolosis)

・StrepA antigen rapid test (streptococcus）

・Mycoplasma antigen rapid test（microplasma）

Key Advantages:
Capilia TB-NEO: WHO endorsement, IVDR certification, Higher accuracy compared to other companies' product Flu, Adeno, RSV: IVDD certification.

Potential Business Partners: 
Importers and Distributors
Companies deal with overseas in vitro diagnostics (Ex: Beckton dickinson SD BIOCENCER, Roche, Abbotto).

Company Info:
Year of Establishment: 1987
No.   of Employees:      253